In this position, I`m accountable for: • Organization and management of all business processes• Managing the implementation of processes in accordance with specific requirements and monitoring their compliance• Agreeing on the project's business goals with management• Realization of business goals• Managing the subordinate team, development, motivating• Organization of tasks and milestones in the project• Monitoring and evaluation of the degree of task implementation, reporting• Ongoing analysis and risk mitigation in the project• Co-creation of the budget and responsibility for its implementationOverseeing compliance with procedures and maintaining the required records in the Quality Management System.

Evaluation and assessment of applications to the National Centre for Research and Development in the area of science and business including market, product, innovation assessment, IPR, project management, financial

Responsible for oversight of multiple international programs within the assigned study portfolio. Line manager of a Project Manager’s team based in PL and the US. Controls of the realization of clinical research studies at all stages. Oversight, of the assigned studies portfolio, demonstrating leadership, ownership, and accountability. Ensures on-time delivery of the assigned portfolio, with quality within budget and according to timelines. Coordinates work of services providers, transparently communicating to the Sponsor all decisions and deviations related to service providers. Collaborates with study level PM and Project Finance Management in the realization of study budget: verifies budget offer, supervises accurate reporting of study costs by Services Providers, oversees value of pass-through costs and CRO remuneration, reacts immediately to deviations or changes that may have an impact on budget realization and propose Change Order, control financial aspects of projects within the assigned project portfolio.

Management of the innovative projects portfolio in several different areas: oncology, CNS, immune diseases, ophthalmology, metabolism, supervision of drug discovery and development programs – until the CTA-filing stage, preparation of CTA, IMPD, IB and clinical plans for phase I and II clinical trials, preparation of Scientific Advice procedures, cross-management and management of multi-department organization, supervision of multiple internal and external activities, cooperation with international organizations, pipeline management and business development, cooperation with business partners and outsourcing companies, development and implementation of drug development strategies, reporting of project progress to the board, strategic analyses of global R&D trends, strategic analyses of the global pharmaceutical market, overseeing and development of preclinical programs for novel chemical compounds and biomolecules – ADME\Tox panels, CMC processes for chemical compounds and biologics, formulation development, formation of research and business alliances and phase I/II clinical trials development, preparation of Scientific Advise applications and registration strategies, preparation and execution of projects schedules and budgets, risk identification and management, business development activities, collaboration with Polish and external VCs, fundraising, grant preparation: Polish structural funds, HORIZON 2020, patent preparations, responsible for the construction and development of the biology/biotechnology part of Celon Pharma R&D Centre – under construction – design of GMP\GLP zones, equipment selection and purchase, design of CHO, microbial and fill and finish (GMP certified) facilities, collaboration with Marketing Department in building the scientific information packages for KOL and physicians, contacting with selected KOLs.

Overall management of the innovative oncology and metabolic projects portfolio, supervision of oncology and metabolic drug discovery and development programs (both small molecules and biologics), coordination and management of multi-department organization (collaboration and management of medicinal chemistry, analytical, in vivo, in vitro, biotechnology and molecular biology teams), supervision of multiple internal and external actions, cooperation with international organizations, pipeline management and business development, cooperation with business partners and outsourcing companies, development and implementation of drug development strategies, reporting of project progress to the board, strategic analysis of global oncology R&D endeavors, strategic analysis of global pharmaceutical oncology market, overseeing and development of preclinical programs for novel oncology biomolecules – ADME\Tox panels, CMC processes for biologics, formation of research and business alliances, collaboration with Marketing Department in building the scientific information packages for KOL and physicians, contacts with KOLs.

Overall management of all subprojects of “3CLA – biologic targeted anticancer therapy” – project, organization of two new research projects: “NCAPT – novel carriers for anticancer therapy”, and “BIOCON – novel targeted anticancer bioconjugates”. I was responsible for the preparation of NCBIR grant applications, supervision of drug discovery and development programs, coordination and management of a multi-department organization, supervision of multiple internal and external actions, cooperation with international organizations, pipeline management and business development, cooperation with business partners and outsourcing companies, development and implementation of drug development strategies, design of novel structures of active biomolecules, reporting of project progress to the board, strategic analysis of global oncology R&D endeavors, strategic analysis of the global pharmaceutical oncology market, overseeing and development of preclinical programs for novel oncology biomolecules – ADME\Tox panels, CMC processes for biologics, directly responsible for designing the concept and overseeing of the execution of the construction of the Celon Pharma Research Center, responsible for the concept design and supervision of works on two biotechnology GMP zones dedicated to mammalian – SUS and bacterial expression, biology and biotechnology, analytical laboratories as well as Small Animal Facility, responsible for acquisition of non-dilutive external founds form National Research Center – NCBR.

Management of two streams of the “3CLA – biologic targeted anticancer therapy” – project, responsible for the creation of a scientific consortium – ONCO-3CLA between Adamed and 17 Polish academia centers and small biotech’s, as well as international CRO, CMO companies and representatives of the academia such as National Cancer Institute and MD Anderson (USA). My work responsibilities were mainly focused on: operational management, cross-management, scientific leadership, establishment of collaboration network with the Polish academia, establishment of the collaboration with CRO, CMC sites and commercial companies from Europe and the USA, management of a multidisciplinary project team, design of novel structures of active biomolecules, reporting of project progress to the board, strategic analysis of global oncology R&D endeavors, strategic analysis of global pharmaceutical oncology market.

Lecturer of the Research Management Course prepared for PhD students.

Assistant professor conducting lectures "Introduction to the Pharmaceutical Biotechnology" - covering the topic of pharmaceutical biotechnology and drug development, supervisor of three master thesis.